SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-22-018808
Filing Date
2022-07-11
Accepted
2022-07-11 16:32:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 pointbiopharma-424b3xposam.htm 424B3 391122
2 back_coverx1a.jpg GRAPHIC 26852
3 prospectus_coverx1a.jpg GRAPHIC 20614
  Complete submission text file 0001628280-22-018808.txt   457687
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258325 | Film No.: 221077262
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences